跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Clindaxin
Approved
STANDARD
Clindaxin
Lloyd Laboratories,Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8a871d2ef08511bd
Company
Lloyd Laboratories,Inc.
Type
Standard
Approval Details
Approval Id
8a871d2ef08511bd
Drug Approval Philippines Name
Clindaxin
Product Name
Clindaxin
Registration Number
DR-XY35083
Brand Name
Clindaxin
Generic Name
Clindamycin (as hydrochloride)
Dosage Form
Capsule
Dosage Strength
150 mg
Manufacturer
Lloyd Laboratories,Inc.
Trader
Zeutica, Inc.
Issuance Date
26 July 2023
Expiry Date
28 October 2028
Pharmacologic Category
Antibacterials
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8a871d2ef08511bd
Type
Standard
Back to Philippines FDA Approvals
Clindaxin - Philippines FDA Drug Approval Details